A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

NCT02953639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Basmisanil
DRUG: Placebo

Sponsor

Hoffmann-La Roche